Intas Pharmaceuticals Limited Etoposide Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Etoposide Export Records India — #1 Exporter, 580 Shipments, $4.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Etoposide

India Pharmaceutical Trade Intelligence

$10.8M237 Suppliers122 CountriesHS 30049045

ExportsIndia → UNITED STATES23.1%India → NETHERLANDS9.2%

ImportsGERMANY → India$492 UNITED STATES → India$402

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Intas Pharmaceuticals Limited — Etoposide Exporter #1 | $5.1M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Etoposide Exporter Profile

Indian Pharmaceutical Exporter · #1 for Etoposide · $5.1M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Etoposide with $5.1M in export value and 580 verified shipments. Intas Pharmaceuticals Limited holds a 44.5% market share in Etoposide exports across 11 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Etoposide Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Etoposide export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Etoposide?

Country	Value	Shipments	Share
UNITED STATES	$2.1M	54	45.5%
NETHERLANDS	$956.8K	148	20.3%
MEXICO	$370.1K	11	7.9%
POLAND	$368.9K	43

Who Are the Top Buyers of Etoposide from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$1.3M	34
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$344.5K	10
AMERISOURCE HEALTH SERVICES	UNITED STATES	$331.2K	7
ACCORD FARMA S A DE C V	MEXICO	$326.2K	10
BROCACEF NL : HUB	NETHERLANDS	$301.3K	74
TO THE ORDER	MALTA	$260.1K	38
ALLOGA FRANCE	NETHERLANDS	$235.4K	23
ACCORD UK	UNITED KINGDOM	$233.2K	15
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$134.6K	20
ACCORD HEALTHCARE SLU	SPAIN	$103.5K	6

Intas Pharmaceuticals Limited supplies Etoposide to 45 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES) and AMERISOURCE HEALTH SERVICES (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Etoposide Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHR DRUGS&MEDI ETOPOSIDE INJ.USP 20MG/ML	$258.2K	6
PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML25ML(US-ACC AS PER INVOICE	$246.7K	5
PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20	$237.3K	5
PHARMA DRUGS & MEDI ETOPOSIDE INJ. USP 2	$234.2K	6
PHARMA DRUGS & MEDI ETOPOSIDE INJ,20MG/M	$194.3K	35
PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML50ML(US-ACC AS PER INVOICE	$166.5K	4
PHARMACEUTICAL DRUGS AND MEDICINE :CAVEPETOPOSIDE 100MG/5ML 1X1VACC MEXICO Eachfilm coated tablet contains: Etoposide	$103.7K	3
PHA.DRU & MEDI, ETOPOSIDE INJ.USP 20MG/M	$88.8K	2
PHA.DRU & MEDI, ETOPOSIDE INJ.USP 20MG/ML25ML(US-ACC EACH ML CONTAINS : ETOPOSIDE #.. 20 MG ANHYDROUS CITRIC	$87.1K	2
PHARMA DRUGS & MEDI ETOPOSIDE INJ USP,20	$70.3K	13

Intas Pharmaceuticals Limited exports 329 distinct Etoposide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHR DRUGS&MEDI ETOPOSIDE INJ.USP 20MG/ML with 6 shipments worth $258.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Etoposide Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$4.8M	580	11	$8.3K
2	FRESENIUS KABI ONCOLOGY LIMITED	$1.9M	126	20	$14.9K
3	VENUS REMEDIES LIMITED	$988.8K	139	20	$7.1K

Intas Pharmaceuticals Limited ranks #1 among 237 Indian Etoposide exporters. Average shipment value of $8.3K compared to the market average of $40.3K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and VENUS REMEDIES LIMITED.

Which Indian Ports Ship Etoposide Exports?

Port	Shipments	% Share
SAHAR AIR	357	16.8%
SAHAR AIR CARGO ACC (INBOM4)	333	15.6%
DELHI AIR	258	12.1%
DELHI AIR CARGO ACC (INDEL4)	244	11.5%
AHEMDABAD AIR ACC (INAMD4)	141	6.6%
AHEMDABAD AIR	135	6.3%
MUNDRA SEA (INMUN1)	129	6.1%
Bombay Air	96	4.5%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Etoposide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Etoposide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 596 individual customs records matching Intas Pharmaceuticals Limited exporting Etoposide, covering 329 formulations to 11 countries via 45 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 598+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Etoposide

Etoposide

Intas Pharmaceuticals Limited — Etoposide Exporter Profile

Intas Pharmaceuticals Limited — Etoposide Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Etoposide?

Who Are the Top Buyers of Etoposide from Intas Pharmaceuticals Limited?

What Is India's Total Etoposide Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Etoposide Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Etoposide Exporters?

What Etoposide Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Etoposide to Key Markets

United States — FDA

Mexico — COFEPRIS

How Does Intas Pharmaceuticals Limited Compare to Nearest Etoposide Exporters?

Which Indian Ports Ship Etoposide Exports?

What Other Oncology Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Etoposide Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Etoposide Export Data from Intas Pharmaceuticals Limited

Etoposide Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source